The US Food and Drug Administration (FDA) has approved more flexible storage and transportation conditions for Pfizer-BioNTech’s Covid-19 vaccine.
The new ruling allows Pfizer-BioNTech’s vaccines to be stored at standard freezer temperatures for up to two weeks and potentially impacts the demand for dry ice, which has been high since the development of the vaccine from last summer.
“Pfizer submitted data to the FDA to support this alternative temperature for transportation and storage,” Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
... to continue reading you must be subscribed
